Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose norepinephrine with restrictive deferred fluids vs goal-directed fluid therapy in elderly VATS
ChiCTR2500105679Phase 4Not yet recruiting
- Sponsor
- Affiliated Cancer Hospital of Guangzhou Medical University
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of norepinephrine in postoperative respiratory complications (PRC) (2 arms), sponsored by Affiliated Cancer Hospital of Guangzhou Medical University. Primary endpoint: postoperative pulmonary complications. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
norepinephrine
03
Conditions
postoperative respiratory complications (PRC)
Beyond the preview
Go deeper on ChiCTR2500105679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105679.